Selected Publications
Rotz SJ, Bjornard K, Hampanda K, Kumnick A, Maher JCY, Yu C, Appiah L. Limited Recommendations and Evidence for Timing and Frequency of Anti-Mullerian Hormone Screening in Female Pediatric Cancer Survivors: A Systematic Review from the Pediatric and Adolescent Committee of the Oncofertility Consortium. J Adolesc Young Adult Oncol Published online November 18, 2024. doi:10.1089/jayao.2024.0111
Ligon JA, Cupit-Link MC, Yu C, Levine J, Foley T, Rotz S, Sharma A, Gomez-Lobo V, Shah NN. Pediatric Cancer Immunotherapy and Potential for Impact on Fertility: A Need for Evidence-Based Guidance. Transplant Cell Ther 2024 Aug;30(8):737-749. doi: 10.1016/j.jtct.2024.06.006. Epub 2024 Jun 10. PMID: 38866240. https://doi.org/10.1016/j.jtct.2024.06.006
Yu C, Delaney A. Clinical Overview: Endocrine Disorders in Pediatric Cancer Survivorship. ClinicalKey Elsevier. 2023 April 18. https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-V2053
Ross J, Bowden MR, Yu C, Diaz-Thomas A. Transition of young adults with metabolic bone diseases to adult care. Front Endocrinol 2023 March 17;14:1137976. https://doi.org/10.3389/fendo.2023.1137976
Lahoti A*, Yu C*, Brar P, Dalgo A, Gomez D, Gourgari E, Harris R, Kamboj M, Marks S, Nandagopal R, Page L, Sarafoglou K, Terrell C, and Stanley TL on behalf of the Pediatric Endocrine Society Drug & Therapeutics Committee. An endocrine perspective on menstrual suppression for adolescents: achieving good suppression while optimizing bone health. J Pediatr Endocrinol Metab Aug 13;34(11):1355-1369, 2021. PMID:34388330. https://doi.org/10.1515/jpem-2020-0539 * co-first authors
Miller R, Ashraf A, Gomez D, Gourgari E, Gupta A, Kamboj M, Kohn B, Lahoti A, Mehta S, Mitchell D, Patel N, Raman V, Yu C, Krishnan S on behalf of the Pediatric Endocrine Society Drug & Therapeutics Committee. SARS-CoV-2 infection and paediatric endocrine disorders: Risks and management considerations. Endocrinol Diabetes Metab Jun 3;4(3):e00262, 2021. PMID: 34268455; PMCID:PMC 8209869. https://doi.org/10.1002/edm2.262
Yu C. Endocrine consequences of childhood cancer therapy and transition considerations. Pediatr Ann Aug 1;48(8):e326-e332, 2019. PMID: 31426101. https://doi.org/10.3928/19382359-20190729-02
Rosenfield RL, Bordini B, Yu C. Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab Apr;98(4):1591-601, 2013. Epub 2013 Mar 1. PMID: 23457407; PMCID:PMC 3615202. https://doi.org/10.1210/jc.2012-4136
Rosenfield RL, Bordini B, Yu C. Comparison of detection of normal puberty in boys by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab Dec;97(12):4596-4604, 2012. Epub 2012 Oct 5. PMID: 23043188; PMCID:PMC 3513543. https://doi.org/10.1210/jc.2012-2722
Gregg B, Kociolek LK, Qin K, Rosenfield RL, Yu C. P450c17 deficiency caused by compound heterozygosity for two novel mutations presenting as hypotension in early infancy. Horm Res Paediatr 76(6):434-41, 2011. Epub 2011 Aug 4. PMID: 21822006. https://doi.org/10.1159/000329857
Yu C, Markan K, Temple KA, Deplewski D, Brady MJ, Cohen RN. The nuclear receptor corepressors NCoR and SMRT decrease PPARg transcriptional activity and repress 3T3-L1 adipogenesis. J Biol Chem Apr 8;280(14):13600-5, 2005. Epub 2005 Feb 3. PMID: 15691842. https://doi.org/10.1074/jbc.m409468200
Temple KA, Cohen RN, Wondisford SR, Yu C, Deplewski D, Wondisford FE. An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements. J Biol Chem Feb 4;280(5):3529-40, 2005. Epub 2004 Nov 29. PMID: 15572375. https://doi.org/10.1074/jbc.m411422200
Cohen RN, Cohen LE, Botero D, Yu C, Sagar A, Jurkiewicz M, Radovick S. Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab Oct;88(10):4832-9, 2003. PMID: 14557462. https://doi.org/10.1210/jc.2002-021868
Last update: February 2025